Xyz secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Hemoptysis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{SSH}} | ||
==Overview== | ==Overview== | ||
There are no established measures for the secondary prevention of | There are no established measures for the secondary prevention of hemoptysis. | ||
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3]. | Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3]. | ||
Line 20: | Line 17: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 21:07, 21 February 2018
Hemoptysis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Xyz secondary prevention On the Web |
American Roentgen Ray Society Images of Xyz secondary prevention |
Risk calculators and risk factors for Xyz secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
There are no established measures for the secondary prevention of hemoptysis. Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- There are no established measures for the secondary prevention of [disease name].
OR
- Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]